INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46m ago
House PTR6m ago
SEC 13F5m ago
Robinhood Chain5m ago

Results

82,053 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Tax withholding
F$342K
2,683 sh
Feb 3, 2026Feb 5, 2026
Page 1609 of 2052
← PrevNext →
traded Feb 3, 2026
+2d
SEC Form 4

Evidence

11
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$7,621
232 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

11
MR
Marion Josh R.SVP and General Counsel
KOSKosmos Energy Ltd.
Open-market sale · 10b5-1 plan
SELL$4,663
3,284 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

11
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
1,547 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
SP
Scherle PeggyChief Scientific Officer
PRLDPrelude Therapeutics Inc
Grant or award
A—
230.0K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
HR
Horn David R.PRESIDENT & CFO
SEERSeer, Inc.
Grant or award
A—
79.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
CM
Chu MaggieSVP, CHRO
LFUSLITTELFUSE INC /DE
Option exercise
M—
2,061 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
KD
Kingdon Mark DDirector
SMGSCOTTS MIRACLE-GRO CO
Option exercise
M—
165 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
HA
Hunton Matthew AEVP, President, Kemper Auto
KMPRKEMPER Corp
Grant or award
A—
27.2K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
KM
Kawaja Joey MSVP, Operations
NENoble Corp plc
Option exercise
M—
3,645 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
DM
Dixton Grant MichaelExecutive Vice President
GMGeneral Motors Co
Grant or award
A—
17.9K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
SJ
Scheiwer Mark JEVP, CFO & CAO
SMGSCOTTS MIRACLE-GRO CO
Tax withholding
F$39K
612 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
EW
Eifler Robert W.Director, President & CEO
NENoble Corp plc
Option exercise
M—
26.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
SW
Simons Aaron WyattDirector, Chief Executive Officer
VIRTVirtu Financial, Inc.
Tax withholding
F—
2,983 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
FW
Flint Christopher WadeEVP, President, Kemper Life
KMPRKEMPER Corp
Tax withholding
F$19K
507 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
WG
Wooley GregEXEC VP OPERATIONS
SKYWSKYWEST INC
Grant or award
A—
2,109 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
BN
Blinde NealPresident, Commercial Banking
COFCAPITAL ONE FINANCIAL CORP
Grant or award
A—
6,794 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
BB
Barker Richard B.EVP and CFO
NENoble Corp plc
Option exercise
M—
9,644 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
AS
Anderson SterlingExective Vice President
GMGeneral Motors Co
Grant or award
A—
40.1K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
RA
Rock Laura AEVP, Chief HR Officer
KMPRKEMPER Corp
Grant or award
A—
20.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
GD
Gizinski DanielPresident, S&S Comm. Segment
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/
Tax withholding
F$2,433
460 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
BK
Balthaser KevinChief Financial Officer
ACRSAclaris Therapeutics, Inc.
Tax withholding
F$22K
6,449 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
HA
Hunton Matthew AEVP, President, Kemper Auto
KMPRKEMPER Corp
Grant or award
A—
1,876 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
RA
Ramamoorthy AnandEVP, Chief Claims Officer
KMPRKEMPER Corp
Grant or award
A—
20.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
AS
Arana SaraChief Accounting Officer
SSBSouthState Bank Corp
Tax withholding
F$13K
122 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
GD
Gizinski DanielPresident, S&S Comm. Segment
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/
Option exercise
M—
1,019 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
CT
Camden Bradley TEVP and CFO
KMPRKEMPER Corp
Tax withholding
F$17K
453 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
BH
Baran Elizabeth H.SVP, General Counsel
DKSDICK'S SPORTING GOODS, INC.
Tax withholding
F$7,512
37 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
CT
Camden Bradley TEVP and CFO
KMPRKEMPER Corp
Grant or award
A—
1,452 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
AA
Alexander James AllenChief Accounting Officer
KMPRKEMPER Corp
Tax withholding
F$8,837
232 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
SC
Saldanha CraigChief Product Officer
YELPYELP INC
Grant or award
A—
19.7K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
BB
Barker Richard B.EVP and CFO
NENoble Corp plc
Option exercise
M—
6,627 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
BM
Brennan Ita MDirector
PLPlanet Labs PBC
Option exercise
M—
423 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
PD
Perlis DanielEVP Sales, Mktg, Business Dev
ELSEQUITY LIFESTYLE PROPERTIES INC
Tax withholding
F$21K
327 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
HR
Harvey RoryExecutive Vice President
GMGeneral Motors Co
Grant or award
A—
22.3K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
EW
Eifler Robert W.Director, President & CEO
NENoble Corp plc
Option exercise
M—
20.9K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
FJ
Fernandes Neil JSenior Vice President
LRCXLAM RESEARCH CORP
Option exercise
M—
14.4K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
FW
Flint Christopher WadeEVP, President, Kemper Life
KMPRKEMPER Corp
Grant or award
A—
19.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
VK
Vaddi KrishnaDirector, CEO
PRLDPrelude Therapeutics Inc
Grant or award
A—
837.0K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Grant or award
A—
5,280 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence